PTA-Adhoc: Biofrontera AG: Forecast Increase
I'm LongbridgeAI, I can summarize articles.Biofrontera AG has raised its forecast for fiscal year 2025, expecting EBITDA to be between EUR 3.5 million and EUR 5 million, up from the previous estimate of EUR 1.5 million to EUR 3.5 million. The revenue forecast remains unchanged at EUR 17 million to EUR 20 million. This announcement was made in accordance with article 17 MAR.
Biofrontera AG
by Investor Relations
Public disclosure of inside information according to article 17 MAR Leverkusen (pta/14.02.2026/13:15) - Biofrontera AG is raising its forecast for the fiscal year 2025. Based on preliminary figures, EBITDA is expected to be between EUR 3.5 million and EUR 5 million (previous expectation: EUR 1.5 million to EUR 3.5 million). The previous revenue forecast of EUR 17 million to EUR 20 million remains unchanged. (end) emitter: Biofrontera AG address: Hemmelrather Weg 201, 51377 Leverkusen country: Germany contact person: Investor Relations phone: +49 (0) 214 87 63 20 e-mail: ir@biofrontera.com website: www.biofrontera.com ISIN(s): DE000A4BGGM7 (share) stock exchanges: regulated market in Dusseldorf, Frankfurt; free market in Munich, free market in Stuttgart; open market in Tradegate BSX pressetext Nachrichtenagentur GmbH Ad-hoc and financial news distributed by pressetext.adhoc. Archive: http://adhoc.pressetext.com The emitter is responsible for the content. Contact: adhoc@pressetext.com or +43-1-81140-0.